This is not the only recall the company is dealing with. Philips’ Respironics business has been facing issues with some of its sleep apnea products since June 2021 when it issued a recall of 15 ...

The issues have largely surrounded the brand's popular DreamStation CPAP ... the consequences of the Respironics recall," said Roy Jakobs, CEO of Royal Philips, in a statement.

The FDA is elevating a recall ... a list of potentially affected patients on a secure website. There, clinicians can request for their ECG reports to be reprocessed and reanalyzed. Philips said ...

Philips is recalling the software associated with its mobile cardiac outpatient telemetry devices after 109 patient injuries and two patient deaths, a Jan. 13 FDA recall notice said. The software ...

The Class I recall, the FDA’s severest classification, is a correction and does not require removing devices from where they are used or sold. Philips started the recall on Nov. 20, 2024 ...